Opportunity Information: Apply for CDC RFA GH11 1152SUPP16
Apply for CDC RFA GH11 1152SUPP16
- The HHS-CDC in the health sector is offering a public funding opportunity titled "Planning, Implementation and Evaluation of Comprehensive HIV Prevention Programs in the Republic of South Africa under PEPFAR" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
- This funding opportunity was created on Jan 08, 2016 and posted on Jan 08, 2016.
- Applicants must submit their applications by Mar 08, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 6 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity, titled "Planning, Implementation and Evaluation of Comprehensive HIV Prevention Programs in the Republic of South Africa under PEPFAR" (Funding Opportunity Number: CDC RFA GH11-1152SUPP16), is a CDC cooperative agreement under CFDA 93.067 focused on expanding HIV prevention programming in South Africa through the DREAMS initiative. The award is being offered through HHS/CDC as part of PEPFAR programming, with an application closing date of March 8, 2016. The opportunity is limited to a defined set of pre-identified eligible applicants rather than being broadly open competition.
Eligibility is restricted to six organizations already named in the announcement: AFSA (GH000233), PSI (GH000243), Shout it Now (GH000285), CMT (GH000293), Soul City (GH000294), and TB/HIV Care (GH000306). The FOA anticipates six awards, aligning with the number of eligible organizations listed. While an award ceiling is not specified in the posted data, the instrument type (cooperative agreement) indicates substantial CDC involvement beyond typical grant oversight, often including ongoing collaboration, shared planning, and close performance monitoring.
The central purpose of the FOA is to fund implementation of the DREAMS initiative, which stands for Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe. DREAMS was launched in 2015 as a USD 210 million partnership involving PEPFAR, the Bill and Melinda Gates Foundation, and the Nike Foundation. Its overarching public health aim is to reduce new HIV infections among adolescent girls and young women (AGYW) across ten sub-Saharan African countries, including South Africa, by combining multiple interventions rather than relying on a single program approach.
A defining feature of DREAMS, reflected in this FOA, is that it goes beyond clinical or health-sector services alone. The initiative is built around layered, evidence-based interventions that also target the structural and social drivers that increase HIV vulnerability for girls and young women. The announcement highlights drivers such as poverty, gender inequality, sexual violence, and limited access to education. In practice, this means programming is expected to address both immediate HIV risk and the broader conditions that shape risk over time.
Geographically, the FOA targets five priority districts in South Africa: eThekwini, uMgungundlovu, and uMkhanyakude in KwaZulu-Natal, and the City of Johannesburg and Ekurhuleni in Gauteng. Across these districts there are 31 sub-districts, with DREAMS concentrating resources in 19 sub-districts identified as high burden and high transmission areas. This targeting reflects a high-impact strategy, directing prevention resources where incidence and transmission risk are most concentrated among AGYW.
Programmatically, the DREAMS initiative objectives in the announcement are organized into four broad pillars: empowering girls and young women, mobilizing communities, strengthening families, and providing social protection. Together these pillars signal a comprehensive prevention model that pairs direct support to AGYW with community norms change, household and caregiver engagement, and practical protections that reduce vulnerability (for example, supports that help girls stay in school or reduce exposure to violence and economic exploitation).
The FOA ties these activities to specific near-term impact goals for AGYW aged 15 to 24. It supports DREAMS targets to reduce new HIV infections in this group by 25% by the end of 2016 and by 40% by the end of 2017. The opportunity also links HIV prevention to broader adolescent wellbeing outcomes, emphasizing improvements that are understood to reduce HIV risk over time, including increased secondary school enrollment, attendance, and completion, as well as reductions in violence and unintended pregnancy. In short, the funding is meant to help selected implementing partners plan, deliver, and evaluate a multi-sector package of interventions in the highest-priority South African districts to achieve measurable reductions in HIV incidence among adolescent girls and young women while improving safety, schooling, and overall resilience.
Frequently Asked Questions (FAQs)
What is the title and funding opportunity number for this grant?
The opportunity is titled "Planning, Implementation and Evaluation of Comprehensive HIV Prevention Programs in the Republic of South Africa under PEPFAR." The Funding Opportunity Number is CDC RFA GH11-1152SUPP16.
Which federal agency is offering this opportunity?
This is offered by HHS/CDC (the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention) as part of PEPFAR programming.
What type of award is this?
The award instrument is a cooperative agreement. This generally indicates substantial CDC involvement beyond standard grant oversight, such as ongoing collaboration, shared planning, and close performance monitoring.
What is the CFDA number associated with this opportunity?
The CFDA number listed for this opportunity is 93.067.
What is the application closing date?
The application closing date shown is March 8, 2016.
Is this opportunity open to the public or broadly competitive?
No. The opportunity is limited to a defined set of pre-identified eligible applicants rather than being open competition.
Who is eligible to apply?
Eligibility is restricted to six organizations named in the announcement: AFSA (GH000233), PSI (GH000243), Shout it Now (GH000285), CMT (GH000293), Soul City (GH000294), and TB/HIV Care (GH000306).
How many awards does CDC anticipate making?
The FOA anticipates six awards, which aligns with the six eligible organizations listed.
Is there an award ceiling listed?
An award ceiling is not specified in the posted information provided for this opportunity.
What is the main purpose of this funding opportunity?
The central purpose is to fund planning, implementation, and evaluation activities supporting the DREAMS initiative to expand comprehensive HIV prevention programming in South Africa under PEPFAR.
What does DREAMS stand for?
DREAMS stands for Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe.
When was the DREAMS initiative launched and who partnered in it?
DREAMS was launched in 2015 as a USD 210 million partnership involving PEPFAR, the Bill and Melinda Gates Foundation, and the Nike Foundation.
What population is DREAMS primarily designed to support?
The initiative focuses on reducing new HIV infections among adolescent girls and young women (AGYW), with the FOA highlighting near-term impact goals for AGYW aged 15 to 24.
What is the overall public health aim of DREAMS in this FOA?
The overall aim is to reduce new HIV infections among adolescent girls and young women by implementing a combination of interventions rather than relying on a single program approach.
Does DREAMS focus only on clinical or health-sector services?
No. A defining feature described in the opportunity is that DREAMS goes beyond clinical or health-sector services alone and includes layered, evidence-based interventions that also address structural and social drivers of HIV vulnerability.
What structural and social drivers are explicitly highlighted?
The announcement highlights drivers such as poverty, gender inequality, sexual violence, and limited access to education.
In which country and geographic areas will activities take place?
Activities are in the Republic of South Africa, targeting five priority districts: eThekwini, uMgungundlovu, and uMkhanyakude in KwaZulu-Natal, and the City of Johannesburg and Ekurhuleni in Gauteng.
How are the priority districts further defined for implementation?
Across the five districts there are 31 sub-districts, and DREAMS concentrates resources in 19 sub-districts identified as high burden and high transmission areas.
What is meant by a "high-impact strategy" in this FOA?
Based on the information provided, it refers to directing prevention resources to the locations where HIV incidence and transmission risk are most concentrated among adolescent girls and young women.
What are the major program pillars described for DREAMS activities?
The objectives are organized into four broad pillars: empowering girls and young women, mobilizing communities, strengthening families, and providing social protection.
What does a "comprehensive" prevention model mean in the context of this FOA?
It means pairing direct support to adolescent girls and young women with community norms change, household and caregiver engagement, and practical protections intended to reduce vulnerability over time.
What near-term HIV impact targets are referenced for AGYW ages 15 to 24?
The FOA supports DREAMS targets to reduce new HIV infections in this group by 25% by the end of 2016 and by 40% by the end of 2017.
Does the opportunity connect HIV prevention to other adolescent wellbeing outcomes?
Yes. It emphasizes improvements understood to reduce HIV risk over time, including increased secondary school enrollment, attendance, and completion, as well as reductions in violence and unintended pregnancy.
What kinds of outcomes beyond HIV incidence are explicitly mentioned?
The announcement mentions schooling outcomes (enrollment, attendance, completion) and reductions in violence and unintended pregnancy as emphasized outcomes alongside HIV prevention.
What is the expected approach to programming under this FOA?
The approach described is a multi-sector, layered package of evidence-based interventions that address both immediate HIV risk and the broader conditions that shape risk over time.
What is the relationship between this FOA and PEPFAR?
The FOA is part of PEPFAR programming and supports implementation of DREAMS within the broader PEPFAR context in South Africa.
What is meant by "planning, implementation, and evaluation" in the title?
Based on the description provided, the funding is intended to support selected implementing partners to plan, deliver, and evaluate the DREAMS package of interventions in the identified priority districts and sub-districts.
Browse more opportunities from the same category: Health
Next opportunity: Support for Strengthening and Expanding HIV/AIDS Surveillance Activities in South Africa under PEPFAR
Previous opportunity: Cooperative Endangered Species Conservation Fund
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH11 1152SUPP16
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH11 1152SUPP16) also looked into and applied for these:
| Funding Opportunity |
|---|
| Support for Strengthening and Expanding HIV/AIDS Surveillance Activities in South Africa under PEPFAR Apply for CDC RFA GH11 1154SUPP16 Funding Number: CDC RFA GH11 1154SUPP16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| The USAID Global Health Development Innovation Accelerator Broad Agency Announcement (BAA) Addendum 03 Apply for BAA GLOBALHEALTH 2016 Funding Number: BAA GLOBALHEALTH 2016 Agency: USAID Category: Health Funding Amount: Case Dependent |
| Centers for Disease Control and Prevention Reduce Hepatitis Infections by Treatment and Integrated Prevention Services (Hepatitis-TIPS) among Non-urban Young Persons Who Inject Drugs Apply for RFA PS 14 00403CONT16 Funding Number: RFA PS 14 00403CONT16 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: Case Dependent |
| NIDCR Small Research Grants for Data Analysis and Statistical Methodology Applied to Genome-wide Data (R03) Apply for PAR 16 070 Funding Number: PAR 16 070 Agency: HHS-NIH11 Category: Health Funding Amount: $200,000 |
| Establishment of a Strategic Partnership to Strengthen the South African National AIDS Council (SANAC) under PEPFAR Apply for CDC RFA GH13 1338SUPP16 Funding Number: CDC RFA GH13 1338SUPP16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| South African University-Based Technical Assistance aimed at Improving the Quality of HIV/AIDS and Related Services in SA under PEPFAR Apply for CDC RFA GH15 1574SUPP16 Funding Number: CDC RFA GH15 1574SUPP16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Support for Health System Strengthening of Leadership, Governance and Quality Improvement in the Ministry of Health (MOH) in the Kingdom of Swaziland under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1584CONT16 Funding Number: CDC RFA GH15 1584CONT16 Agency: HHS-CDC Category: Health Funding Amount: $685,000 |
| Comprehensive Facility-Based Technical Assistance in the Context of Health Systems Strengthening in South Africa under PEPFAR Apply for CDC RFA GH12 1257SUPP16 Funding Number: CDC RFA GH12 1257SUPP16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Secretary’s Minority AIDS Initiative Funding to Increase HIV Prevention and Care Service Delivery among Health Centers Serving High HIV Prevalence Jurisdictions Apply for CDC RFA PS14 141003CONT16 Funding Number: CDC RFA PS14 141003CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Sodium Reduction in Communities Apply for CDC RFA DP16 1607 Funding Number: CDC RFA DP16 1607 Agency: HHS-CDC-NCCDPHP Category: Health Funding Amount: $500,000 |
| Well Integrated Screening and Evaluation for Women Across the Nation (WISEWOMAN) Program Apply for CDC RFA DP13 130204CONT16 Funding Number: CDC RFA DP13 130204CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Building Ryan White HIV/AIDS Program Recipient Capacity to Engage People Living with HIV in Health Care Access Apply for HRSA 16 081 Funding Number: HRSA 16 081 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Ryan White HIV/AIDS Part C Capacity Development Program Apply for HRSA 16 088 Funding Number: HRSA 16 088 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| State Public Health Approaches to Improving Arthritis Outcomes Apply for CDC RFA DP12 121005CONT16 Funding Number: CDC RFA DP12 121005CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| International Research Ethics Education and Curriculum Development Award (R25) Apply for PAR 16 081 Funding Number: PAR 16 081 Agency: HHS-NIH11 Category: Health Funding Amount: $230,000 |
| Cohort Study to Assess Population Impact of Current and Evolving Chronic Viral Hepatitis Treatment Apply for RFA PS 16 002 Funding Number: RFA PS 16 002 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: $500,000 |
| NIDCD National Human Ear Tissue Laboratory Resource for Hearing and Balance Research (U24) Apply for RFA DC 17 001 Funding Number: RFA DC 17 001 Agency: HHS-NIH11 Category: Health Funding Amount: $475,000 |
| 2016 Cooperative Agreements to Benefit Homeless Individuals (Short Title: CABHI) Apply for SM 16 007 Funding Number: SM 16 007 Agency: HHS-SAMHS Category: Health Funding Amount: $1,500,000 |
| State Public Health Actions to Prevent and Control Diabetes, Heart Disease, Obesity and Associated Risk Factors and Promote School Health Apply for CDC RFA DP13 130504CONT16 Funding Number: CDC RFA DP13 130504CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Ryan White HIV/AIDS Program Part F Dental Reimbursement Program Apply for HRSA 16 089 Funding Number: HRSA 16 089 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH11 1152SUPP16", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
